Header Logo

Connection

DIMA SUKI to Interleukin-2

Back to Details
This is a "connection" page, showing publications DIMA SUKI has written about Interleukin-2.
DIMA SUKI
Connection Strength
0.061
Interleukin-2
  1. A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2. Cancer. 1998 Jan 15; 82(2):403-11.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.